Sort
16,300 grants matching “fatty liver disease”
Inborn Errors of Long Chain Fat Metabolism
$325,032Gerard Vockley · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · DK
Viral Hepatitis C and Lipid Homeostasis
$325,029Aleem Siddiqui · University Of California, San Diego · R01 · FY2010 · DK
HIV-Associated Macrophage Alterations and Progressive Liver Disease
$325,001Raymond T Chung · Massachusetts General Hospital · R01 · FY2019 · DK
HIV-Associated Macrophage Alterations and Progressive Liver Disease
$325,000Raymond T Chung · Massachusetts General Hospital · R01 · FY2015 · DK
HIV-Associated Macrophage Alterations and Progressive Liver Disease
$325,000Raymond T Chung · Massachusetts General Hospital · R01 · FY2017 · DK
HIV-Associated Macrophage Alterations and Progressive Liver Disease
$325,000Raymond T Chung · Massachusetts General Hospital · R01 · FY2016 · DK
Lipid Mediators of Insulin Resistance
$324,903Scott A Summers · Duke University · R01 · FY2012 · DK
Lipid Mediators of Insulin Resistance
$324,903Scott A Summers · Duke University · R01 · FY2011 · DK
Interaction of Nutrient & Organochlorine Absorption
$324,870Patrick Powing Tso · University Of Cincinnati · R01 · FY2008 · ES
Interaction of Nutrient & Organochlorine Absorption
$324,870Patrick Powing Tso · University Of Cincinnati · R01 · FY2009 · ES
Control of ketogenesis by epinephrine and GPR109A
$324,850Matthew Whim · Lsu Health Sciences Center · R01 · FY2015 · DK
Control of ketogenesis by epinephrine and GPR109A
$324,850Matthew Whim · Lsu Health Sciences Center · R01 · FY2017 · DK
Control of ketogenesis by epinephrine and GPR109A
$324,850Matthew Whim · Lsu Health Sciences Center · R01 · FY2016 · DK
ROCK and Obesity
$324,776James Kuang-Jan Liao · Brigham And Women'S Hospital · R01 · FY2011 · DK
Clinical utility of leptin therapy in syndromic forms of insulin resistance.
$324,768Rebecca Brown · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Apolipoprotein CIII inhibition in partial lipodystrophy
$324,768Rebecca Brown · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Guideline-based surveillance and treatment of hepatocellular carcinoma
$324,738Jessica A Davila · Baylor College Of Medicine · R01 · FY2012 · CA
Deciphering the role of TREM2 in Non-Alcoholic Steatohepatitis
$324,720Shuang Liang · Ut Southwestern Medical Center · R01 · FY2025 · DK
The Role of Gm4951 in Nonalcoholic Fatty Liver Disease
$324,720Zhao Zhang · Ut Southwestern Medical Center · R01 · FY2025 · DK
Inflammatory Regulation of Lipid Accumulation in Skeletal Muscle with Obesity
$324,710Matthew W Hulver · Virginia Polytechnic Inst And St Univ · R01 · FY2012 · DK
Mechanisms of Metabolic Control by MKP-1
$324,681Anton M Bennett · Yale University · R01 · FY2011 · DK
TCDD inductions of omega-6 and omega-3 PUFA metabolism act inversely on tumor progression
$324,526Oliver None Hankinson · University Of California Los Angeles · R01 · FY2016 · ES
TCDD inductions of omega-6 and omega-3 PUFA metabolism act inversely on tumor progression
$324,526Oliver None Hankinson · University Of California Los Angeles · R01 · FY2017 · ES
Discovery and optimization of novel, selective HDAC11 inhibitors for the treatment of obesity and related diseases.
$324,466Dawn Bell · Myracle Therapeutics Inc · R44 · FY2024 · DK
Regulation of hepatic metabolism by metformin
$324,438Morris J Birnbaum · University Of Pennsylvania · P01 · FY2012 · DK